|
ZNF616 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.37509999959585E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.679900E-03 |
| Normal-vs-Stage2 |
3.056700E-03 |
| Normal-vs-Stage3 |
4.58500004629769E-09 |
| Normal-vs-Stage4 |
2.60470000013058E-07 |
| Stage1-vs-Stage2 |
2.351600E-01 |
| Stage1-vs-Stage3 |
1.589460E-04 |
| Stage1-vs-Stage4 |
9.369000E-04 |
| Stage2-vs-Stage3 |
1.223570E-01 |
| Stage2-vs-Stage4 |
1.520020E-01 |
| Stage3-vs-Stage4 |
9.178600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37810000003336E-06 |
| Normal-vs-AfricanAmerican |
1.61955999999908E-05 |
| Normal-vs-Asian |
7.818600E-01 |
| Caucasian-vs-AfricanAmerican |
3.817600E-02 |
| Caucasian-vs-Asian |
2.730600E-01 |
| AfricanAmerican-vs-Asian |
7.924300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.95860000002024E-06 |
| Normal-vs-Female |
3.20050000002237E-06 |
| Male-vs-Female |
6.486200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.532100E-02 |
| Normal-vs-Age(41-60Yrs) |
9.030100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.43289999976481E-07 |
| Normal-vs-Age(81-100Yrs) |
1.94890000027037E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.959000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.976800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.641900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.634300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.141700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.307900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.666200E-01 |
| Normal-vs-Grade 2 |
1.189500E-02 |
| Normal-vs-Grade 3 |
1.93520000024705E-08 |
| Normal-vs-Grade 4 |
5.68979996451446E-09 |
| Grade 1-vs-Grade 2 |
2.314400E-01 |
| Grade 1-vs-Grade 3 |
7.444600E-03 |
| Grade 1-vs-Grade 4 |
1.837190E-03 |
| Grade 2-vs-Grade 3 |
4.041800E-04 |
| Grade 2-vs-Grade 4 |
2.31859999999529E-05 |
| Grade 3-vs-Grade 4 |
4.454500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.164300E-02 |
| Normal-vs-ccB subtype |
2.27500000005154E-06 |
| ccA subtype-vs-ccB subtype |
2.277200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.189890E-04 |
| Normal-vs-N1 |
2.06909999999061E-05 |
| N0-vs-N1 |
5.656400E-02 |
|
|
